Why is Revvity (RVTY) stock rocketing higher today

What happened

Revvity shares jumped 12.2% in the morning session after the life sciences company reported third-quarter 2026 revenue of $728.9 million, up 10.3% year over year, and beat Wall Street estimates. It also raised full-year guidance to about $2.86 billion in revenue.

Confirmed

Global impact / market context

Beating sales and profit expectations signals customers are still buying Revvity's products, and a higher full-year outlook tells investors management expects that demand to continue. This can support future sales and profit, which is why the stock rose sharply.

Analyst inference

Revvity shares are volatile, with 15 moves greater than 5% in the past year. A 12.2% jump is rare even for this stock, showing investors saw the earnings beat and raised outlook as a meaningful change in the business outlook.

Analyst inference

What to watch

1. Watch whether Revvity delivers the roughly $2.86 billion full-year revenue and $5.43 midpoint adjusted earnings per share it now targets, since missing those raised goals could reverse the stock's gain. Confirmed
2. Company guidance is a forecast, not a guarantee. Watch future quarterly reports for whether sales growth and adjusted earnings per share keep pace with the raised targets rather than slowing. Proposed
3. Watch how sustainable the 7% organic revenue growth is, that is growth excluding currency and deal effects, because a slowdown could pressure sales and weaken the case for the higher outlook. Analyst inference

Evidence

• stockstory.org